Actively Recruiting
Phase III Randomized Study of Once Weekly Petrelintide Versus Placebo for Weight Management in Adults With Overweight or Obesity and Type 2 Diabetes
Led by Hoffmann-La Roche · Updated on 2026-10-07
600
Participants Needed
2
Research Sites
13 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the efficacy and safety of petrelintide compared with a placebo in adults with overweight or obesity who also have Type 2 Diabetes T2D. This Phase III study aims to understand how petrelintide works alongside a reduced-calorie diet and increased physical activity to help manage weight in this population. Participants will receive either petrelintide or a matching placebo, both administered once weekly by subcutaneous injection using a drug-device combination product. The study lasts 64 weeks, during which participants will follow a reduced-calorie diet and increase physical activity. The trial compares the effects of petrelintide versus placebo over this period. Throughout the study, participants will have regular assessments measuring changes in body weight, waist circumference, blood sugar control HbA1c, physical functioning, hunger and appetite scores, cholesterol levels, blood pressure, and quality of life. Safety will be monitored by tracking adverse events and the presence of antibodies against petrelintide. The studys main measurement is the percentage change in body weight from the start to week 64, with ongoing evaluations of multiple health and quality of life indicators.
CONDITIONS
Brief Title
A Phase III Study to Evaluate the Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Type 2 Diabetes
Research Team
R
Reference Study ID Number: CC46369 https://forpatients.roche.com/No attachments to email below.
F
Fastest Response: use the inquiry form. https://www.gene.com/contact-us/submit-medical-inquiry
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here